BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37907779)

  • 1. Oncogene SCARNA12 as a potential diagnostic biomarker for colorectal cancer.
    Zhang H; Liu X; Zhang W; Deng J; Lin C; Qi Z; Li Y; Gu Y; Wang Q; Shen L; Wang Z
    Mol Biomed; 2023 Nov; 4(1):37. PubMed ID: 37907779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer.
    Lu Q; Wang J; Tao Y; Zhong J; Zhang Z; Feng C; Wang X; Li T; He R; Wang Q; Xie Y
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339238
    [No Abstract]   [Full Text] [Related]  

  • 3. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
    Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
    Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway.
    Sun K; Wang S; He J; Xie Y; He Y; Wang Z; Qin L
    Oncotarget; 2017 Dec; 8(64):107932-107946. PubMed ID: 29296214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNORA21 - An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer.
    Yoshida K; Toden S; Weng W; Shigeyasu K; Miyoshi J; Turner J; Nagasaka T; Ma Y; Takayama T; Fujiwara T; Goel A
    EBioMedicine; 2017 Aug; 22():68-77. PubMed ID: 28734806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNE4 expression is correlated with the pathological characteristics of colorectal cancer patients and associated with the radioresistance of cancer cells.
    Tian K; Tao Z; Chen Y; Du J; Chen M; Wang D; Li Z
    Pathol Res Pract; 2023 Jan; 241():154234. PubMed ID: 36459833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
    Liu J
    Exp Cell Res; 2023 Sep; 430(1):113694. PubMed ID: 37391010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
    Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
    Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer.
    Wu H; Qin W; Lu S; Wang X; Zhang J; Sun T; Hu X; Li Y; Chen Q; Wang Y; Zhao H; Piao H; Zhang R; Wei M
    Mol Cancer; 2020 May; 19(1):95. PubMed ID: 32443980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.